Details of the Drug | DrugMAP

General Information of Drug (ID: DMX2TEM)

Drug Name

LOR-2040

Indication

Disease Entry	ICD 11	Status	REF
Acute myeloid leukaemia	2A60	Phase 2	[1]
Breast cancer	2C60-2C65	Phase 2	[1]
Metastatic colorectal cancer	2B91	Phase 2	[1]
Metastatic renal cancer	2D50	Phase 2	[1]
Prostate cancer	2C82.0	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D0I7NG

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	ClinicalTrials.gov (NCT00087165) GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancer. U.S. National Institutes of Health.